These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15768346)

  • 21. Direct observation therapy-highly active antiretroviral therapy in a resource-limited setting: the use of community treatment support can be effective.
    Idoko JA; Agbaji O; Agaba P; Akolo C; Inuwa B; Hassan Z; Akintunde L; Badung B; Muazu M; Danang M; Imade G; Sankale JL; Kanki P
    Int J STD AIDS; 2007 Nov; 18(11):760-3. PubMed ID: 18005510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addressing the need for treatment paradigms for drug-abusing patients with multiple morbidities.
    Kresina TF; Normand J; Khalsa J; Mitty J; Flanigan T; Francis H
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S398-401. PubMed ID: 15156429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic approach to the treatment of HIV and hepatitis C virus infection in the inner city: a Canadian perspective.
    Conway B; Grebely J; Tossonian H; Lefebvre D; de Vlaming S
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S73-8. PubMed ID: 16265619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues.
    Celentano DD; Lucas G
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S318-23. PubMed ID: 18190306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents.
    McCance-Katz EF
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S89-95. PubMed ID: 16265622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
    Spire B; Lucas GM; Carrieri MP
    Int J Drug Policy; 2007 Aug; 18(4):262-70. PubMed ID: 17689374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of clinic-based modified-directly observed therapy (m-DOT) for ART; experiences in Mombasa, Kenya.
    Munyao P; Luchters S; Chersich MF; Kaai S; Geibel S; Mandaliya KN; Temmerman M; Rutenberg N; Sarna A
    AIDS Care; 2010 Feb; 22(2):187-94. PubMed ID: 20390497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive clinical adherence interventions to enable antiretroviral therapy: a case report.
    Nicca D; Moody K; Elzi L; Spirig R
    J Assoc Nurses AIDS Care; 2007; 18(6):44-53. PubMed ID: 17991598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivering therapy for hepatitis C virus infection to incarcerated HIV-seropositive patients.
    McGovern B; Fiore J; Wurcel A; Taglienti P; Bradley M; Galvin S; Libone G; Ramsey J; Molinaro-Gudas V; Drewniak S; Amick C; Andalkar A; Scheft H; Bica I
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S56-62. PubMed ID: 16265615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interrelation between psychiatric disorders and the prevention and treatment of HIV infection.
    Treisman G; Angelino A
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S313-7. PubMed ID: 18190305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
    Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
    J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
    Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Schizophrenia and comorbid human immunodeficiency virus or hepatitis C virus.
    Cournos F; McKinnon K; Sullivan G
    J Clin Psychiatry; 2005; 66 Suppl 6():27-33. PubMed ID: 16107181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment interruptions in HIV-infected subjects.
    Bongiovanni M; Casana M; Tincati C; d'Arminio Monforte A
    J Antimicrob Chemother; 2006 Sep; 58(3):502-5. PubMed ID: 16816398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.